Markets.com Logo
markets.com

ATRX

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    --
  • Previous Close
    --
  • 52 Week Change
    --
  • Day Range
    --
  • 52 Week High/Low
    --
  • Dividend Per Share
    --
  • Market cap
    --
  • EPS
    --
  • Beta
    --
  • Volume
    --

About

ATRX.US represents the common stock of Arca Biopharma, Inc. traded on the Nasdaq Stock Market. Arca Biopharma is a biopharmaceutical company focused on developing genetically targeted therapies for cardiovascular diseases. Their lead product candidate, Gencaro, is a pharmacogenetic therapy being developed for the prevention of atrial fibrillation in patients with heart failure and atrial fibrillation. The ".US" suffix simply indicates that the stock is traded on a US exchange.
markets.com
Micron vs SanDisk: Which Stock Is Better Positioned for AI Growth?

Micron vs SanDisk: Which Stock Is Better Positioned for AI Growth?

Julian Parker|--
AMD vs Intel vs Arm: Which Stock Could Benefit Most From the AI Inference Boom?

AMD vs Intel vs Arm: Which Stock Could Benefit Most From the AI Inference Boom?

Daniel Carter|--
AMD Joins the $1 Trillion Club as AI Demand Lifts Shares: AI Chip Stock Forecast and Outlook

AMD Joins the $1 Trillion Club as AI Demand Lifts Shares: AI Chip Stock Forecast and Outlook

Julian Parker|--
British Pound Short-Term Outlook: Can GBP/USD Hold 1.33 as Fed–BoE Policy Divergence Widens?

British Pound Short-Term Outlook: Can GBP/USD Hold 1.33 as Fed–BoE Policy Divergence Widens?

Julian Parker|--
Stellar XLM Price Prediction 2026, 2027 & 2030: Can XLM Reach $1?

Stellar XLM Price Prediction 2026, 2027 & 2030: Can XLM Reach $1?

Daniel Carter|--

The energy sector remains a hot topic & precious metals

Darius Anucauskas|--
Dollar to Mexican Peso Forecast 2026–2030: Can USD/MXN Break Above 17.50 as the Rate Gap Narrows?

Dollar to Mexican Peso Forecast 2026–2030: Can USD/MXN Break Above 17.50 as the Rate Gap Narrows?

Julian Parker|--

Factors

ATRX.US Stock Price Influencers: Overall Market Sentiment: Broad market trends, economic data, and investor confidence heavily influence ATRX.US. A bullish market generally lifts ATRX, while a bearish one drags it down. Company Performance: ATRX's revenue, earnings, and growth prospects directly impact its stock price. Positive financial results typically boost investor confidence. Industry Trends: Developments within the biotechnology and pharmaceutical sectors, including new drug approvals, regulatory changes, and competitor activities, shape investor perception of ATRX. Clinical Trial Outcomes: Results from ATRX's clinical trials are crucial. Positive outcomes for drug candidates typically lead to stock price surges, while negative results can cause declines. Regulatory Approvals: FDA decisions on ATRX's drug candidates significantly affect the stock. Approvals usually increase the price, while rejections decrease it. Competition: The presence and success of competing drugs from other companies impact ATRX's market share and potential revenue, thus influencing the stock price. Partnerships and Collaborations: Strategic alliances and collaborations with other companies can enhance ATRX's prospects and boost investor confidence. Management Changes: Significant changes in ATRX's leadership or management team can influence investor sentiment and impact the stock price. Analyst Ratings: Recommendations and price targets from financial analysts can influence investor decisions and affect ATRX's stock price. Economic Conditions: Macroeconomic factors such as interest rates, inflation, and economic growth can affect investor sentiment and overall market conditions, indirectly impacting ATRX. Investor Sentiment: General investor perception of ATRX, influenced by news, social media, and other sources, can drive buying or selling pressure, affecting the stock price. Intellectual Property: The strength and protection of ATRX's patents and intellectual property rights are critical for its long-term value and influence stock price.

People Also Watch

Latest news

Gold Price Today: Gold Holds Near $4,280 After Strong US PMI Sends Treasury Yields Higher

Gold Price Today: Gold Holds Near $4,280 After Strong US PMI Sends Treasury Yields Higher

Julian Parker|--
McDonald’s Stock Falls Nearly 5% as NEXT Investor Day Raises Turnaround Questions

McDonald’s Stock Falls Nearly 5% as NEXT Investor Day Raises Turnaround Questions

Julian Parker|--
Treasury Yields Spike After Strong US PMI as Nasdaq Falls More Than 1%

Treasury Yields Spike After Strong US PMI as Nasdaq Falls More Than 1%

Julian Parker|--

Latest Education Articles

Risk Management 101

Risk Management 101

Julian Parker|--
Best AI Stocks to Buy Now: 10 Best Performing AI Stocks to Watch in 2026

Best AI Stocks to Buy Now: 10 Best Performing AI Stocks to Watch in 2026

Julian Parker|--
Gold Scalping Strategy: How Scalping XAU/USD Works

Gold Scalping Strategy: How Scalping XAU/USD Works

Julian Parker|--
Recommended Topics
markets.com